1
|
González-Enguita C, Garcia-Giménez R, Garcia-Guinea J, Correcher V. Spectral characterization of renal calculi collected from population in downtown Madrid (Spain). Spectrochim Acta A Mol Biomol Spectrosc 2024; 304:123395. [PMID: 37716040 DOI: 10.1016/j.saa.2023.123395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 08/18/2023] [Accepted: 09/09/2023] [Indexed: 09/18/2023]
Abstract
This paper reports on a comprehensive approach to characterize a set of kidney stones through various analytical techniques including ESEM-EDS, XRD, Raman, and CL spectroscopy, linked to an assessment of the patient's lifestyle and dietary habits. The use of these techniques can provide valuable insights into the underlying causes of stone formation and guide strategies for prevention and treatment. ESEM-EDS and XRD are commonly used techniques for kidney stone characterization due to their complementary nature, enabling the identification of a wide range of renal calculi. However, these techniques may not be sensitive enough to determine the detailed composition of the samples. In such cases, Raman and CL techniques can be used to provide more precise information about the chemical and structural composition of the stones. Raman spectroscopy, for example, can identify molecular phases observed under an optical microscope characterizing chemical compositions through vibrational modes associated with specific bonds. The CL spectral emission within the 250-850 nm range can also yield valuable information about the mineral phases, including the identification of structural crystallinity, hydrated molecules, Ca-OH bonds, and oxygen defects. By correlating spectral analyses with patient habits, this study identifies potential exogenous factors contributing to stone formation, including excess protein consumption, urinary bacterial infections, and oxalate-rich diets. This comprehensive approach provides a more complete understanding of the composition of kidney stones helping to personalized prevention and treatment strategies.
Collapse
Affiliation(s)
- C González-Enguita
- Hospital Univ. Fundación Jiménez Díaz, Av. Reyes Católicos 2, 28040 Madrid, Spain
| | - R Garcia-Giménez
- Dpto. Geología y Geoquímica. Fac. Ciencias, Univ. Autónoma, 28049 Madrid, Spain
| | - J Garcia-Guinea
- Museo Nacional de Ciencias Naturales (CSIC), c/José Gutierrez Abascal 2, Madrid 28006, Spain
| | - V Correcher
- CIEMAT, Av. Complutense 40, Madrid 28040, Spain.
| |
Collapse
|
2
|
González-Enguita C, Bueno-Serrano G, López de Alda-González A, García-Giménez R. Environmental Conditions as Determinants of Kidney Stone Formation. ACS Appl Bio Mater 2023; 6:5030-5036. [PMID: 37913796 PMCID: PMC10863387 DOI: 10.1021/acsabm.3c00722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 10/20/2023] [Accepted: 10/23/2023] [Indexed: 11/03/2023]
Abstract
Urolithiasis is a disease characterized by the presence of stones in the urinary tract, whether in the kidneys, ureters, or bladder. Its origin is multiple, and causes can be cited as hereditary, environmental, dietary, anatomical, metabolic, or infectious factors. A kidney stone is a biomaterial that originates inside the urinary tract, following the principles of crystalline growth, and in most cases, it cannot be eliminated naturally. In this work, 40 calculi from the Don Benito, Badajoz University Hospital are studied and compared with those collected in Madrid to establish differences between both populations with the same pathology and located in very different geographical areas. Analysis by cathodoluminescence offers information on the low crystallinity of the phases and their hydration states, as well as the importance of the bonds with the Ca cation in all of the structures, which, in turn, is related to environmental and social factors of different population groups such as a high intake of proteins, medications, bacterial factors, or possible contamination with greenhouse gases, among other factors.
Collapse
Affiliation(s)
- Carmen González-Enguita
- Hospital
Universitario Fundación Jiménez Díaz, Avenida Reyes Católicos,
2, 28040 Madrid, Spain
| | - Gonzalo Bueno-Serrano
- Hospital
Universitario Fundación Jiménez Díaz, Avenida Reyes Católicos,
2, 28040 Madrid, Spain
| | | | - Rosario García-Giménez
- Departamento
de Geología y Geoquímica, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, Spain
| |
Collapse
|
3
|
Seguí-Moya E, Amorós-Torres A, Centeno-Álvarez C, Gutiérrez-Zurimendi G, Nuno de la Rosa I, Escudero-Fontano E, Sierra Del Río A, Moreno-Fontela MP, Sánchez-García M, Mir-Maresma MC, Musquera-Felip M, Ribal-Caparrós MJ, López-Díez E, González-Enguita C. Women in urology: what is their current situation in Spain? Actas Urol Esp 2023; 47:462-469. [PMID: 37442224 DOI: 10.1016/j.acuroe.2023.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Accepted: 05/19/2023] [Indexed: 07/15/2023]
Abstract
OBJECTIVE To analyze the current state of women in urology in Spain. MATERIAL AND METHODS Descriptive study based on the results of an online survey sent between February and April 2020 through the database of the Residents and Young Urologists group (RAEU) of the Spanish Association of Urology (AEU). Characteristics of the survey and its results were analyzed. RESULTS In total, 257 responses were obtained from 210 women (81.71%) and 47 men (18.29%) belonging to 111 hospitals. Statistically significant differences were observed (p < 0.001) with a higher proportion of men in all categories except for the group of young female and male attendings (29-39 years, p = 0.789), and the group of female residents against male residents (p = 0.814). The number of men was higher in hospitals with subspecialty units except for the Pelvic Floor Unit, where no statistically significant difference was observed (p = 0.06). Regarding positions of responsibility, only 7 out of 111 hospitals had female Department Chiefs. CONCLUSIONS Women's representation in urology is increasing, mainly due to the younger generations. However, the access of these women to relevant positions is anecdotal.
Collapse
Affiliation(s)
- E Seguí-Moya
- Neuro-Urology Department, Royal National Orthopaedic Hospital, Londres, United Kingdom.
| | - A Amorós-Torres
- Servicio de Urología, Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain
| | - C Centeno-Álvarez
- Servicio de Urología, Hospital Parc Taulí, Sabadell, Barcelona, Spain
| | | | - I Nuno de la Rosa
- Servicio de Urología, Hospital General Universitario de Elda, Elda, Alicante, Spain
| | - E Escudero-Fontano
- Servicio de Urología, Hospital de la Vega Baja, Orihuela, Alicante, Spain
| | - A Sierra Del Río
- Servicio de Urología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
| | - M P Moreno-Fontela
- Servicio Urología, Hospital Universitario del Henares, Coslada, Madrid, Spain
| | | | - M C Mir-Maresma
- Servicio de Urología, Hospital Universitari de La Ribera, Alzira, Valencia, Spain
| | - M Musquera-Felip
- Servicio de Urología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
| | - M J Ribal-Caparrós
- Servicio de Urología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
| | - E López-Díez
- Servicio de Urología, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain
| | - C González-Enguita
- Servicio de Urología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
| |
Collapse
|
4
|
Angulo JC, Téllez C, Giammò A, González-Enguita C, Schoenburg S, Queissert F, Szczesniewski J, González R, Romero A, Gonsior A, Martins FE, Antunes-Lopes T, Cruz F, Rourke K. Results of Adjustable Trans-Obturator Male System in Patients with Prostate Cancer Treated with Prostatectomy and Radiotherapy: A Multicenter Study. J Clin Med 2023; 12:4721. [PMID: 37510835 PMCID: PMC10380664 DOI: 10.3390/jcm12144721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2023] [Revised: 07/12/2023] [Accepted: 07/14/2023] [Indexed: 07/30/2023] Open
Abstract
(1) Background: Treatment of male stress incontinence in patients with prostate cancer treated with radical prostatectomy and adjuvant pelvic radiation is a therapeutic challenge. The efficacy and safety of the adjustable trans-obturator male system (ATOMS) in these patients is not well established, despite the general belief that outcomes are worse than in patients without radiation. (2) Methods: Retrospective multicenter study evaluating patients treated with silicone-covered scrotal port (SSP) ATOMS implant after radical prostatectomy and radiotherapy in nine different institutions between 2016 and 2022. The primary endpoint was dry patient rate, defined as pad-test ≤ 20 mL/day. The secondary endpoints were complication rate (defined using Clavien-Dindo classification), device removal and self-perceived satisfaction using the Patient Global Impression of Improvement (PGI-I) scale. Wilcoxon rank-sum test, Fisher's exact test and logistic regression were performed using stepwise method with a 0.15 entry and 0.1 stay criteria. (3) Results: 223 patients fulfilled the criteria for inclusion and 12 (5.4%) received salvage prostatectomy after radiation and 27 (12.1%) previous devices for stress incontinence. After ATOMS adjustment, 95 patients (42.6%) were dry and 36 (16.1%) had complications of any grade (grade I, n = 20; grade II, n = 11; grade III, n = 5) during the first 3 months postoperatively. At a mean of 36 ± 21 months follow-up, the device was explanted in 26 (11.7%) patients. Regarding self-perceived satisfaction with the implant, 105 of 125 patients (84%) considered themselves satisfied (PGI-I 1 to 3). In the univariate analysis, dryness was associated to younger age (p = 0.06), primary prostatectomy (p = 0.08), no previous incontinence surgery (p = 0.02), absence of overactive bladder symptoms (p = 0.04), absence of bladder neck stricture (p = 0.001), no need of surgical revision (p = 0.008) and lower baseline incontinence severity (p = 0.0003). Multivariate analysis identified absence of surgical revision (p = 0.018), absence of bladder neck stricture (p = 0.05), primary prostatectomy (p = 0.07) and lower baseline incontinence severity (p < 0.0001) were independent predictors of dryness. A logistic regression model was proposed and internally validated. (4) Conclusions: ATOMS is an efficacious and safe alternative to treat male incontinence after radical prostatectomy and adjuvant radiotherapy. Factors predictive of dryness are identified in this complex scenario to allow for better patient selection.
Collapse
Affiliation(s)
- Javier C Angulo
- Clinical Department, Faculty of Biomedical Science, Universidad Europea, Carretera de Toledo, Km 12.500, Getafe, 28905 Madrid, Spain
- Department of Urology, Hospital Universitario de Getafe, Carretera de Toledo, Km 12.500, Getafe, 28905 Madrid, Spain
| | - Carlos Téllez
- Clinical Department, Faculty of Biomedical Science, Universidad Europea, Carretera de Toledo, Km 12.500, Getafe, 28905 Madrid, Spain
- Department of Urology, Hospital Universitario de Getafe, Carretera de Toledo, Km 12.500, Getafe, 28905 Madrid, Spain
| | - Alessandro Giammò
- Department of Neuro-Urology, CTO/Spinal Cord Unit, AOU Città Della Salute e Della Scienza di Torino, Via Zuretti 24, 10126 Torino, Italy
| | - Carmen González-Enguita
- Department of Urology, Hospital Fundación Jiménez Díaz, Av. de Los Reyes Católicos, 2, 28040 Madrid, Spain
| | - Sandra Schoenburg
- Department of Urology and Kidney Transplantation, Martin Luther University, Ernst-Grube-Straße 40, 06120 Halle (Saale), Germany
| | - Fabian Queissert
- Department of Urology and Pediatric Urology, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany
| | - Juliusz Szczesniewski
- Department of Urology, Hospital Universitario de Getafe, Carretera de Toledo, Km 12.500, Getafe, 28905 Madrid, Spain
| | - Raquel González
- Department of Urology, Hospital Fundación Jiménez Díaz, Av. de Los Reyes Católicos, 2, 28040 Madrid, Spain
| | - Antonio Romero
- Department of Urology, Hospital Universitario Morales Meseguer, Avd. Marqués de Los Vélez s/n., 30008 Murcia, Spain
| | - Andreas Gonsior
- Klinik und Poliklinik für Urologie, University of Leipzig, Liebigstraße 20, 04103 Leipzig, Germany
| | - Francisco E Martins
- Department of Urology, Centro Hospitalar Universitário de Lisboa Norte, Hospital Santa María, Av. Prof. Egas Moniz MB, 1649-028 Lisboa, Portugal
| | - Tiago Antunes-Lopes
- Department of Urology, Centro Hospitalar São João and Faculty of Medicine of University Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
- I3S Institute, R. Alfredo Allen 208, 4200-135 Porto, Portugal
| | - Francisco Cruz
- Department of Urology, Centro Hospitalar São João and Faculty of Medicine of University Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
- I3S Institute, R. Alfredo Allen 208, 4200-135 Porto, Portugal
| | - Keith Rourke
- Department of Urology, Alberta University, Hospital Edmonton, 8440 112 St. NW, Edmonton, AB T6G 2B7, Canada
| |
Collapse
|
5
|
Pérez-Aizpurua X, Garranzo-Ibarrola M, Simón-Rodríguez C, García-Cardoso JV, Chávez-Roa C, López-Martín L, Tufet i Jaumot JJ, Alonso-Román J, Maqueda-Arellano J, Gómez-Jordana B, Ruiz de Castroviejo-Blanco J, Osorio-Ospina F, González-Enguita C, García-Arranz M. Stem Cell Therapy for Erectile Dysfunction: A Step towards a Future Treatment. Life (Basel) 2023; 13:life13020502. [PMID: 36836859 PMCID: PMC9963846 DOI: 10.3390/life13020502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 01/17/2023] [Accepted: 02/09/2023] [Indexed: 02/15/2023] Open
Abstract
Background: The improvement of absent or partial response in the medical treatment of erectile dysfunction (ED) has led to the development of minimally invasive new treatment modalities in the field of regenerative medicine. Methods: A literature review on stem cell therapy for the treatment of ED was performed. We searched for the terms "erectile dysfunction" and "stem cell therapy" in PubMed and Clinicaltrials.gov. Literature searching was conducted in English and included articles from 2010 to 2022. Results: New treatment modalities for ED involving stem cell therapy are not only conceived with a curative intent but also aim to avoid unnecessary adverse effects. Several sources of stem cells have been described, each with unique characteristics and potential applications, and different delivery methods have been explored. A limited number of interventional studies over the past recent years have provided evidence of a safety profile in their use and promising results for the treatment of ED, although there are not enough studies to generate an appropriate protocol, dose or cell lineage, or to determine a mechanism of action. Conclusions: Stem cell therapy is a novel treatment for ED with potential future applications. However, most urological societies agree that further research is required to conclusively prove its potential benefit.
Collapse
Affiliation(s)
- Xabier Pérez-Aizpurua
- Urology Department, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain
- Correspondence:
| | | | | | | | - César Chávez-Roa
- Urology Department, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain
| | - Leticia López-Martín
- Urology Department, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain
| | | | - Josué Alonso-Román
- Urology Department, Hospital Universitario Virgen de la Macarena, 41009 Sevilla, Spain
| | | | - Blanca Gómez-Jordana
- Urology Department, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain
| | | | - Felipe Osorio-Ospina
- Urology Department, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain
| | | | - Mariano García-Arranz
- Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain
| |
Collapse
|
6
|
Pérez-Aizpurua X, Monzó-Gardiner JI, Maqueda-Arellano J, Buendía-González E, Cuello-Sánchez L, Tufet I Jaumot JJ, Alonso-Román J, Gómez-Jordana Mañas B, Ruiz de Castroviejo Blanco J, Osorio Ospina F, Cabello Benavente R, González-Enguita C. BCG shortage for intravesical instillation is associated with early tumoral recurrence in patients with high-risk non-muscle invasive bladder tumours. Actas Urol Esp 2023; 47:250-258. [PMID: 36754206 DOI: 10.1016/j.acuroe.2023.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 12/16/2022] [Accepted: 12/19/2022] [Indexed: 02/08/2023]
Abstract
INTRODUCTION During 2019 there was a worldwide shortage of BCG strains for intravesical instillation, limiting the availability of full dose schemes for maintenance courses. The main objective was to analyze the impact on tumoral relapse secondary to BCG shortage in our center. Secondary outcomes included recurrence and progression-free survival rates and tumoral relapse specific characteristics. METHODS Retrospective cohort study including 158 subjects (64 treated during 2019 and 94 during 2017) with high-risk non-muscle invasive bladder cancer and treated with a combination of Transurethral bladder resection (TURB) followed by adjuvant intravesical instillation with BCG in a tertiary hospital in Spain. Basal characteristics of both groups were analyzed. Times to event of interest (relapse; including recurrence and/or progression) were estimated with Kaplan-Meier survival analysis. Disease-free survival rates were analyzed using a multivariable Cox regression model of proportional hazards. RESULTS Median follow-up in the 2019 sample was 24 months and 50 months in the 2017 group with a median number of instillations of 8 and 12 respectively. Median time to relapse of 285 days (145-448) during 2019 and 382 days (215-567) in 2017 were observed (logRank p = 0.025). Further multivariable analysis revealed a proportional hazard ratio (HR) for disease-free survival rate of 1.87 (95% CI: 1.04-3.37 p = 0.036). No statistically significant differences in tumoral relapse characteristics were observed. CONCLUSION BCG shortage and subsequent reduced-dose schemes used for intravesical instillation due to limited availability, increase early tumoral relapse rates. These findings are consistent with available evidence, showing the need for full-dose BCG courses.
Collapse
Affiliation(s)
- X Pérez-Aizpurua
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain.
| | - J I Monzó-Gardiner
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | - J Maqueda-Arellano
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | - E Buendía-González
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | - L Cuello-Sánchez
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | - J J Tufet I Jaumot
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | - J Alonso-Román
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | | | | | - F Osorio Ospina
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | - R Cabello Benavente
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| | - C González-Enguita
- Department of Urology, Fundación Jíménez Diaz University Hospital, Madrid, Spain
| |
Collapse
|
7
|
Pérez-Aizpurua X, Monzó-Gardiner J, Maqueda-Arellano J, Buendía-González E, Cuello-Sánchez L, Tufet i Jaumot J, Alonso-Román J, Gómez-Jordana Mañas B, Ruiz de Castroviejo Blanco J, Osorio Ospina F, Cabello Benavente R, González-Enguita C. El desabastecimiento de BCG para instilación intravesical se asocia a la recidiva tumoral precoz en pacientes con tumor de vejiga superficial de alto riesgo. Actas Urol Esp 2023. [DOI: 10.1016/j.acuro.2022.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
8
|
Coloma L, Cabello R, Bueno G, Quicios C, García-Cardoso JV, González-Enguita C. [Renal harvest. State of the art.]. ARCH ESP UROL 2021; 74:933-940. [PMID: 34851308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Kidney transplantation (KT) is the best treatment for end-stage renal disease. Despite Spain isone of the leading countries in donation, the need for transplantable organs exceeds the available supply. Graft survival depends on the quality of the organ, the damage it suffers during the donation and transplantation process, as well as the risk of rejection. Among the factors that must be controlled and minimized are the ischemia-reperfusion injuries that occurs in the moments surrounding the death of the donor, the procurement and the preservation of the organ until kidney transplantation. Static cold storage is the traditional method of preservation of the organ until the moment of implantation, since it is a technique with wide availability and low cost. The use of perfusion machines in DCD and expanded criteria has shown better short-term results (primary failur delayed on set of function) without affecting recipient orgraft survival. The objective of our article is to review the current situationand the resources available to increase the pool of transplantable organs and their quality. We conducted a systematic review on kidney extraction, donor management, preservation methods and techniques to optimize cadaveric donor kidney donation.
Collapse
Affiliation(s)
- Lidia Coloma
- Servicio de Urología. Unidad de trasplante renal. Hospital Universitario Fundación Jiménez Díaz. Madrid. España
| | - Ramiro Cabello
- Servicio de Urología. Unidad de trasplante renal. Hospital Universitario Fundación Jiménez Díaz. Madrid. España
| | - Gonzalo Bueno
- Servicio de Urología. Unidad de trasplante renal. Hospital Universitario Fundación Jiménez Díaz. Madrid. España
| | - Cristina Quicios
- Servicio de Urología. Unidad de trasplante renal. Hospital Universitario Fundación Jiménez Díaz. Madrid. España
| | - Juan Vicente García-Cardoso
- Servicio de Urología. Unidad de trasplante renal. Hospital Universitario Fundación Jiménez Díaz. Madrid. España
| | - Carmen González-Enguita
- Servicio de Urología. Unidad de trasplante renal. Hospital Universitario Fundación Jiménez Díaz. Madrid. España
| |
Collapse
|
9
|
Jiménez-Pompa A, Sanz-Lázaro S, Hone AJ, Rueda-Ruzafa L, Medina-Polo J, González-Enguita C, Blázquez J, de Los Ríos C, Michael McIntosh J, Albillos A. Therapeutic concentrations of varenicline increases exocytotic release of catecholamines from human and rat adrenal chromaffin cells in the presence of nicotine. Neuropharmacology 2021; 195:108632. [PMID: 34097947 DOI: 10.1016/j.neuropharm.2021.108632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 04/30/2021] [Accepted: 05/20/2021] [Indexed: 11/29/2022]
Abstract
Cardiovascular side effects of varenicline and a case report of a hypertensive crisis in a varenicline-prescribed patient with pheochromocytoma have been reported. The goal of the present study was to determine whether such side effects might derive, in part, from increased exocytosis of secretory vesicles and subsequent catecholamine release triggered by varenicline in human chromaffin cells of the adrenal gland. In this study, we performed electrophysiological plasma membrane capacitance and carbon fiber amperometry experiments to evaluate the effect of varenicline on exocytosis and catecholamine release, respectively, at concentrations reached during varenicline therapy (100 nM). Experiments were conducted in the absence or presence of nicotine, at plasma concentrations achieved right after smoking (250 nM) or steady-state concentrations (110 nM), in chromaffin cells of the adrenal gland obtained from human organ donors. Cells were stimulated with short pulses (10 ms) of acetylcholine (ACh; 300 μM) applied at 0.2 Hz, in order to closer mimic the physiological situation at the splanchnic nerve-chromaffin cell synapse. In addition, rat chromaffin cells were used to compare the effects obtained in cells from a more readily available species. Varenicline increased the exocytosis of secretory vesicles in human and rat chromaffin cells in the presence of nicotine, effects that were not due to an increase of plasma membrane capacitance or currents triggered by the nicotinic agonists alone. These results should be considered in nicotine addiction therapies when varenicline is used.
Collapse
Affiliation(s)
- Amanda Jiménez-Pompa
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain; Instituto-Fundación Teófilo Hernando, Universidad Autónoma de Madrid, Madrid, Spain
| | - Sara Sanz-Lázaro
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain
| | - Arik J Hone
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain; School of Biological Sciences and Department of Psychiatry, University of Utah, Salt Lake City, Utah, USA
| | - Lola Rueda-Ruzafa
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain
| | - José Medina-Polo
- Servicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación I+12, Madrid, Spain
| | | | - Jesús Blázquez
- Servicio de Urología, Hospital Clínico San Carlos, Madrid, Spain
| | | | - J Michael McIntosh
- School of Biological Sciences and Department of Psychiatry, University of Utah, Salt Lake City, Utah, USA
| | - Almudena Albillos
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain; Instituto Ramón y Cajal de Investigación Biosanitaria (IRYCIS), Madrid, Spain.
| |
Collapse
|
10
|
Garde-García H, González-López R, González-Enguita C. [Comparative study between patients undergoing laparoscopic colposacropexy with and without prior surgery for the treatment of apical prolapse]. ARCH ESP UROL 2021; 74:564-570. [PMID: 34219058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
INTRODUCTION Colposacropexy is the treatment of choice for apical prolapse. Studies comparing this technique as primary surgery for pelvic organprolapse (POP), with its success in recurrent POPs after surgery, are scarce. MATERIALS AND METHODS Retrospective analysis of a series of patients diagnosed with POP who underwent laparoscopic colposacropexy, comparing a group without previous prolapse surgery with another group that has recurred after previous surgery (with or without mesh). Our objective was to analyze the differences regarding surgical time (skin to skin), intraoperative complications, mean stay, resolution of symptoms and recurrence. As preoperative data, we compared: age, body mass index (BMI), parity, previous hysterectomy, physical examination, symptoms, and flowmetry; and as peri/postoperative data: follow-up, intervention duration, intra and postoperative complications, mean stay, physical examination (Baden-Walker classification), symptom resolution and flowmetry. RESULTS Twenty-three patients have been operated on in 12 months. Nine (39.1%) were recurrent POPs after previous surgery, 6 (66.7%) of them with some type of mesh. Follow-up (mean months): 6.44 ± 4.19 (previous cx) vs. 4.79 ± 4.00. Both groups were comparable with respect to preoperative variables. Previously operated patients had greater dyspareunia (p<0.05). We did not find differences in the rest of symptoms between both groups. There were no differences in the duration of the intervention, mean stay, or regarding intraoperative complications (p>0.05) between both groups. Sensation of vaginal lump, urge incontinence and dyspareunia resolved in all patients. Flowmetry improved in both groups (p>0.05). CONCLUSIONS Laparoscopic colposacropexy is an effective and safe technique to correct POP after previous surgery, with or without mesh.
Collapse
Affiliation(s)
- Héctor Garde-García
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz. Madrid. España
| | | | | |
Collapse
|
11
|
Hernández-Sánchez J, Hernández-Sánchez T, García-Gómez F, Valverde-Martínez S, Padilla Fernandez B, Márquez-Sánchez M, Márquez-Sánchez G, Flores-Fraile M, García-Cenador M, González-Enguita C, Lorenzo Gomez M. Relationship between the clinical profile of women with recurrent urinary tract infections and the prophylactic treatment chosen. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00545-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
12
|
Angulo JC, Schönburg S, Giammò A, Queissert F, Gonsior A, González-Enguita C, Martins FE, Rourke K, Cruz F. Artificial urinary sphincter or a second adjustable transobturator male system offer equivalent outcomes in patients whom required revision on the initial ATOMS device: An international multi-institutional experience. Neurourol Urodyn 2021; 40:897-909. [PMID: 33645867 DOI: 10.1002/nau.24646] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 02/05/2021] [Accepted: 02/14/2021] [Indexed: 11/11/2022]
Abstract
AIM To evaluate treatment options after surgical revision of adjustable transobturator male system (ATOMS) and the results of further incontinence implantation. MATERIALS AND METHODS A retrospective multicenter study evaluating patients with surgical revision of ATOMS in academic institutions. Causes and factors affecting revision-free interval were studied and also the frequency of device explant and placement of second ATOMS or artificial urinary sphincter (AUS) at surgeon discretion. Operative results, complications (Clavien-Dindo), and efficacy (postoperative pad-test, pad-count, patient satisfaction, and patient global impression of improvement [PGI-I scale]) of each treatment option were compared. RESULTS Seventy-eight out of 902 patients (8.65%) with ATOMS underwent surgical revision at 4.1 ± 2.4 years mean follow-up and 75 (8.3%) were explanted. The main causes for revision included persistence of incontinence (35.9%) and scrotal port erosion (34.6%). Independent risk factors of the shortened revision-free interval were previous anti-incontinence surgery (HR, 1.83; 95% CI, 1.06-3.16; p = 0.007) and port erosion (HR, 1.83; 95% CI, 1.06-3.16; p = 0.0027). Fifty-eight (6.4%) received a second implant: 31 repeated ATOMS and 27 AUS. Operative time was longer for AUS (p = .003). The visual analog scale of pain at hospital discharge (p = 0.837) and postoperative complications (p = 0.154) were equivalent. The predominant cuff size for AUS was 4.5 cm (59.3%). Mean follow-up after the second implant was 29.1 ± 25.8 months. Postoperative efficacy of secondary treatment results favored ATOMS based on pad-test (p = 0.016), pad-count (p = 0.029), patient satisfaction (p = 0.04), and PGI-I (p = 0.025). CONCLUSIONS ATOMS surgical revision due to different reasons generally leads to device explant. Rescue treatment is possible with ATOMS or AUS. No difference in postoperative complications was detected between secondary devices, but efficacy favors repeating ATOMS implantation.
Collapse
Affiliation(s)
- Javier C Angulo
- Clinical Department, Universidad Europea de Madrid, Hospital Universitario de Getafe, Madrid, Spain
| | - Sandra Schönburg
- Department of Urology and Kidney Transplantation, Martin Luther University, Halle (Saale), Germany
| | - Alessandro Giammò
- Department of Neuro-Urology, CTO/Spinal Cord Unit, AOU Città della Salute e della Scienza di Torino, Turin, Italy
| | - Fabian Queissert
- Department of Urology, Universitätsklinikum Münster, Münster, Germany
| | - Andreas Gonsior
- Klinik und Poliklinik für Urologie, University of Leipzig, Leipzig, Germany
| | | | - Francisco E Martins
- Centro Hospitalar Universitário de Lisboa Norte, Hospital Santa María, Lisboa, Portugal
| | - Keith Rourke
- Department of Urology, Alberta University, Edmonton, Alberta, Canada
| | - Francisco Cruz
- Department of Urology, Centro Hospitalar São João, Oporto, Portugal
| |
Collapse
|
13
|
López-Martín L, Alcover-Díaz J, Charry-Gónima P, González-López R, Rodríguez-Gil D, Palacios-Peláez R, González-Enguita C. Prospective Observational Cohort Study of the Efficacy of Bacterial Immune Prophylaxis in the Prevention of Uncomplicated, Recurrent Urinary Tract Infections. Urol Int 2019; 102:449-455. [PMID: 30917371 DOI: 10.1159/000497107] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2018] [Accepted: 01/21/2019] [Indexed: 11/19/2022]
Abstract
OBJECTIVE To investigate the long-term prophylactic effect of a vaccine on lower urinary tract infections (UTI) of bacterial and the impact of the intensity of the symptoms on the quality of life (QoL). METHODS Adult female could be enrolled in this study if they had acute UTI at the enrolment visit and bacterial microbiological count of ≥103 CFU/mL of Escherichia coli. RESULTS A total of 21 patients were included. Fifteen days after the administration of a vaccine for 3 months, the number of infections dropped almost to zero. Significant differences were observed in the QoL score (p < 0.05). The safety profile was good. CONCLUSIONS In patients diagnosed with recurrent UTI and treated for 3 months with the vaccine the number of UTI episodes fell very quickly (15 days), and patients remained free of episodes and improved their QoL significantly for 1 year. These results suggest that bacterial vaccines are a possible effective alternative in the prevention of recurrent UTI.
Collapse
Affiliation(s)
- Leticia López-Martín
- Urology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain,
| | - Javier Alcover-Díaz
- Operations and Research and Development Managers, Laboratorio Diater, Madrid, Spain
| | - Paula Charry-Gónima
- Urology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
| | | | - David Rodríguez-Gil
- Operations and Research and Development Managers, Laboratorio Diater, Madrid, Spain
| | | | | |
Collapse
|
14
|
Simón-Rodríguez C, González-Enguita C, Vela-Navarrete R. Polycystosis of the renal sinus or polycystic kidney disease Controversies, challenges and history of a shared discovery. Actas Urol Esp 2018; 42:645-648. [PMID: 30518488 DOI: 10.1016/j.acuro.2018.03.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2018] [Accepted: 03/21/2018] [Indexed: 10/28/2022]
Abstract
OBJECTIVE To recall the history of the discovery of non-nephron cystic disease, detected simultaneously in 2 hospitals in Madrid, and the vicissitudes that the authors endured during the process of recognising this disease, while being ignored by the international scientific literature. MATERIAL AND METHOD We analysed the authors' first publications and presentations, their correspondence relaying the difficulties in reporting the confusion with adult polycystic kidney disease (APKD) and the subsequent nosological identification of the process. We consulted with individuals who worked with the 2 authors to increase the accuracy and objectivity of the history report. RESULTS We confirmed the authors' remarkable efforts in getting the process definitively recognised despite the notable difficulties. CONCLUSIONS Rigorous clinical observation recognises processes ignored by the medical literature, and the correct application of the scientific method helps identify and reveal new nosological entities, confirming with this story's example that, in medicine, there are no exhausted issues.
Collapse
|
15
|
Quicios-Dorado C, Bolufer-Moragues E, Gomis-Goti C, Cabello-Benavente R, Cannata-Ortiz PJ, González-Enguita C. [Aggressive variants of castration resistant prostate cancer (CRPC): neuroendocrine prostate cancer.]. ARCH ESP UROL 2018; 71:721-734. [PMID: 30319132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Castration resistant prostate cancer (CRPC) is characterized by an important molecular, pathological and clinical heterogeneity. Although most of them present androgen receptor (AR) signal dependence, there are independent phenotypes. Neuroendocrine prostate cancer (NEPC) is a rare histologic subtype with adverse prognosis due to late diagnosis, heterogeneous clinical features and lack of effective systemic treatments. Platinum based chemotherapy is the standard treatment, presenting short limited responses. There are pure forms or mixed with adenocarcinoma component. De novo diagnosis is unusual, being more frequent in advanced stages of prostate cancer, as a consequence of the inhibition of androgen receptor performed by various treatments. Thus, it could represent an aggressive evolution from carcinoma through a NEEpithelial transdifferentiation. Development of preclinical studies has permitted characterization of molecular and genomic alterations associated with this evolution and they may help to develop new therapeutic targets. Over the last years, there have been important advances in identification and characterization of clinical and pathological CRPC variants. NEPC is one of the most aggressive subtypes. A better knowledge of the disease biology is necessary to develop new treatments and biomarkers that help to manage this aggressive variant of PC.
Collapse
Affiliation(s)
- Cristina Quicios-Dorado
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz (HUFJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Eduardo Bolufer-Moragues
- Servicio de Urología. Hospital Universitario Infanta Elena. Universidad Francisco de Vitoria. Valdemoro, Madrid. España
| | - Carmen Gomis-Goti
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz (HUFJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Ramiro Cabello-Benavente
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz (HUFJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Pablo Javier Cannata-Ortiz
- Servicio de Anatomía Patológica. Hospital Universitario Fundación Jiménez Díaz (HUFJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Carmen González-Enguita
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz (HUFJD)y Hospitales Públicos Grupo QuirónSalud Madrid. Universidad Autónoma de Madrid (UAM). Madrid. España
| |
Collapse
|
16
|
González-Enguita C. Comment to «Costs and hospital procedures in an urology department of a tertiary hospital. Analysis of groups related by their diagnosis». Actas Urol Esp 2017; 41:409-410. [PMID: 27955858 DOI: 10.1016/j.acuro.2016.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2016] [Accepted: 11/08/2016] [Indexed: 10/20/2022]
Affiliation(s)
- C González-Enguita
- Servicio de Urología, Hospital Universitario Fundación Jiménez Díaz, Hospitales de asistencia pública del grupo QuirónSalud, Madrid, España.
| |
Collapse
|
17
|
González-Enguita C, Gennaro-DellaRossa N, López-López E, Escobar-Castaño J, Rodríguez-Castro PM, González-López R. [Current status of laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse.]. ARCH ESP UROL 2017; 70:400-411. [PMID: 28530619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVES Surgical restoration of pelvic floor anatomy in pelvic organ prolapse (POP) should avoid extensive areas that may injure healthy tissues and lead to scar fibrosis producing dysfunctional rigidity. Laparoscopic sacrocolpopexy corrects POP by lifting pelvic elements with a minimally invasive procedure.Various current strategies and approaches make it a diverse procedure. METHODS We performed a bibliographic review on the published experience about abdominal sacrocolpopexy over the last 20 years. We analyze the philosophy of each technique, advantages, disadvantages, and results. RESULTS Among current theories that explain how is the anatomy and function of the pelvic floor, the comprehensive theory of the pelvic floor announces that anatomical deviation produces pelvic dysfunction (diagnostic algorithm)(1). Surgical invasion with reconstructive purposes may hide results if the true physiopathology of the defects found is not known. Although current diagnostic tools cannot solve the problem as a whole, results of different techniques are much better than those of previous times. CONCLUSIONS Laparoscopic sacrocolpopexy is an adequate strategy that restores anatomy in POP, mainly apical, and function with minimal invasion. Technical development and better knowledge of the female pelvis functional anatomy is enabling today a more precise understanding of its physiopathology, so it facilitates the design of site-specific operations. Various surgical approaches and techniques are offered depending on the defect, where combined procedures give good solutions. It is necessary to have an appropriate surgical training to obtain the better competence, and a safe and correct repair.
Collapse
Affiliation(s)
- Carmen González-Enguita
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz. Universidad Autónoma Madrid. España
| | | | - Esther López-López
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz. Universidad Autónoma Madrid. España
| | - Juliana Escobar-Castaño
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz. Universidad Autónoma Madrid. España
| | | | - Raquel González-López
- Servicio de Urología. Hospital Universitario Fundación Jiménez Díaz. Universidad Autónoma Madrid. España
| |
Collapse
|
18
|
Hone AJ, Michael McIntosh J, Rueda-Ruzafa L, Passas J, de Castro-Guerín C, Blázquez J, González-Enguita C, Albillos A. Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells. J Neurochem 2016; 140:37-52. [PMID: 27805736 DOI: 10.1111/jnc.13883] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2016] [Revised: 10/20/2016] [Accepted: 10/27/2016] [Indexed: 01/13/2023]
Abstract
Varenicline is a nicotinic acetylcholine receptor (nAChR) agonist used to treat nicotine addiction, but a live debate persists concerning its mechanism of action in reducing nicotine consumption. Although initially reported as α4β2 selective, varenicline was subsequently shown to activate other nAChR subtypes implicated in nicotine addiction including α3β4. However, it remains unclear whether activation of α3β4 nAChRs by therapeutically relevant concentrations of varenicline is sufficient to affect the behavior of cells that express this subtype. We used patch-clamp electrophysiology to assess the effects of varenicline on native α3β4* nAChRs (asterisk denotes the possible presence of other subunits) expressed in human adrenal chromaffin cells and compared its effects to those of nicotine. Varenicline and nicotine activated α3β4* nAChRs with EC50 values of 1.8 (1.2-2.7) μM and 19.4 (11.1-33.9) μM, respectively. Stimulation of adrenal chromaffin cells with 10 ms pulses of 300 μM acetylcholine (ACh) in current-clamp mode evoked sodium channel-dependent action potentials (APs). Under these conditions, perfusion of 50 or 100 nM varenicline showed very little effect on AP firing compared to control conditions (ACh stimulation alone), but at higher concentrations (250 nM) varenicline increased the number of APs fired up to 436 ± 150%. These results demonstrate that therapeutic concentrations of varenicline are unlikely to alter AP firing in chromaffin cells. In contrast, nicotine showed no effect on AP firing at any of the concentrations tested (50, 100, 250, and 500 nM). However, perfusion of 50 nM nicotine simultaneously with 100 nM varenicline increased AP firing by 290 ± 104% indicating that exposure to varenicline and nicotine concurrently may alter cellular behavior such as excitability and neurotransmitter release.
Collapse
Affiliation(s)
- Arik J Hone
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain.,Departments of Biology, University of Utah, Salt Lake City, Utah, USA
| | - J Michael McIntosh
- Departments of Biology, University of Utah, Salt Lake City, Utah, USA.,Psychiatry, University of Utah, Salt Lake City, Utah, USA.,The George E. Whalen Veterans Affairs Medical Center, Salt Lake City, Utah, USA
| | - Lola Rueda-Ruzafa
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain
| | | | | | | | | | - Almudena Albillos
- Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain
| |
Collapse
|
19
|
Vela-Navarrete R, González-Enguita C, Calahorra J, García-Cardoso JV. Vena cava haemodynamics and haemorrhage during thrombectomy in renal tumour surgery. Actas Urol Esp 2016; 40:537-538. [PMID: 27059631 DOI: 10.1016/j.acuro.2016.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2015] [Revised: 03/03/2016] [Accepted: 03/03/2016] [Indexed: 11/28/2022]
Affiliation(s)
- R Vela-Navarrete
- Servicio de Urología, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, España.
| | - C González-Enguita
- Servicio de Urología, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, España
| | - J Calahorra
- Servicio de Urología, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, España
| | - J V García-Cardoso
- Servicio de Urología, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, España
| |
Collapse
|
20
|
Cabello-Benavente R, González-Enguita C. Residency in urology and training in kidney transplantation. Results of a national survey. Actas Urol Esp 2015; 39:303-9. [PMID: 25449295 DOI: 10.1016/j.acuro.2014.09.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2014] [Revised: 09/04/2014] [Accepted: 09/05/2014] [Indexed: 12/12/2022]
Abstract
OBJECTIVES To determine the current state of kidney transplantation (KT) training in a country that is leader in organ donation and transplantation. MATERIAL AND METHODS We conducted an online survey by e-mail to 138 urology residents. The survey contained 5 sections: affiliation, training in KT, interest in KT, residents of transplant centers and residents of nontransplant centers. RESULTS Sixty-five residents responded, 47.1% of the urologists in training surveyed, representing 28 cities and 15 provinces. Fifty-five percent (n=36) of the respondents deemed the KT training offered during their residency as insufficient, and 85% (n=55) demanded more resources. More than half were not confident in their abilities to perform transplantation surgery over the course of their residency (n=35). Nineteen percent of the residents considered KT an important discipline in their residency, with a mean score of 56.2 (1-100). Among the residents of the transplant centers (69.2%, n=45), 73% (n=33) considered KT when choosing a center for their residency. Of the surveyed residents from nontransplant centers (30.7%, n=20), 45% (n=9) do not perform an external rotation in KT. CONCLUSIONS The surveyed residents demand more training in KT. The most common situation is to end a residency without having performed a complete KT. KT is considered an asset when selecting a resident medical intern position and commonly they are part of the transplantation team. The majority of residents are trained in centers with less than 75 transplants/year. External rotations in KT are not the rule in centers where transplantation is not performed.
Collapse
|
21
|
Husillos-Alonso A, Simón-Rodríguez C, Bolufer-Moragues E, López-Martín L, Carbonero-García M, González-Enguita C. [[Greenlight-XPS laser vaporization, the new standard of treatment in men with myasthenia gravis and benign prostatic obstruction]?]. ARCH ESP UROL 2015; 68:441-443. [PMID: 26033765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
UNLABELLED Patients with Benign Prostatic Obstruction (BPO) and Myasthenia Gravis (MG) treated with Transurethral Resection of the prostate (TURP) show a high incidence of urinary incontinence due to unnoticed damage to muscle fibres of the external sphincter. Photoselective laser vaporization could be an alternative treatment based on the hypothesis that using Laser as energy source in the treatment of BPH prevents sphincter damage because the energy is not transmitted outside the fiber tip. METHODS We report the case of a man diagnosed of MG and symptomatic BPO treated satisfactorily with photoselective laser vaporization (GreenLight-XPS). RESULTS Patient did not experienced postoperative secondary incontinence. CONCLUSIONS Laser photoselective vaporization (GreenLight-XPS) could be the standard treatment for men with MG and BPO, whose prostate volume is less than 60 cc who are candidates for surgical treatment. Despite the extremely low incidence of these cases, further investigations are needed to confirm this affirmation.
Collapse
Affiliation(s)
- Adrián Husillos-Alonso
- Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Carlos Simón-Rodríguez
- Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Eduardo Bolufer-Moragues
- Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Leticia López-Martín
- Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Manuel Carbonero-García
- Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| | - Carmen González-Enguita
- Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España
| |
Collapse
|
22
|
González-Enguita C, Autrán-Gómez AM, Sánchez-Encinas M, Carbonero-García M, García-Cardoso JV, Hernández-Sanchez JE, García-Menéndez C. [Adequacy of urology departments in a health care model of hospitals network]. ARCH ESP UROL 2015; 68:105-114. [PMID: 25688536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
UNLABELLED The traditional health care model is currently facing new health requirements. The implementation of integrated urologic health systems can be one of the possible solutions to these needs. It is mandatory to explore a new health care model, which includes structural and organizational changes. The adequacy of the urology departments of IDCsalud-Madrid network hospitals, creating URORed, is a new system adaptable to constant changes, in order to offer professionalism and quality health care. OBJECTIVE To describe the administrative/clinic management in the urology service of a health care model of Hospitals network (URORed at IDCsalud. Madrid), that has been included in a model of an Integrated network in a health care service. METHODS In the period between November 2007 to October 2014, the urology departments of IDCsalud Madrid Group, have been included in a new organizational system, including 4 hospitals, currently with 27 urologists. Each center offers specific urologic services, sharing benefits and human resources. The same directive line leads all centers. RESULTS The model offers an integrated and uniform urologic service to a specific population of 811.390 habitants (Population Census 2012), with capability to treat specific urologic diseases and to perform a correct clinical follow-up. CONCLUSIONS Belonging to a health care model in network involves a change of attitude. It creates an organizational change, based on the processes and the results, which enables control of the management analytically, detecting the points that need to be optimized as well as those that are satisfactory. It implies developing a culture of learning and cooperation, so that the processes are fluent and have quality, to create clinical and technological projects in favor of new resource-generating research, based on the needs of the joint management of the hospitals network. The complexity of this model requires a work focused on the human resources, their concerns and their ability to coordinate actions to get results in terms of quality health care and professionalism.
Collapse
Affiliation(s)
- C González-Enguita
- Urología en Red (UroRed) Hospital Universitario Fundación Jiménez Díaz (Madrid). Universidad Autónoma de Madrid
| | | | | | | | | | | | | |
Collapse
|
23
|
Vela-Navarrete R, González-Enguita C, Rodríguez-Miñón JL, Calahorra J. Renal grafting and the short right renal vein technical inconveniences. Actas Urol Esp 2013; 37:457-8. [PMID: 23769896 DOI: 10.1016/j.acuro.2013.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2013] [Accepted: 04/11/2013] [Indexed: 11/19/2022]
Affiliation(s)
- R Vela-Navarrete
- Servicio de Urología y Unidad de Trasplante Renal, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, España.
| | | | | | | |
Collapse
|
24
|
González-López R, Bueno-Serrano G, Vázquez-Escuderos JJ, Mayor-De Castro J, González-Enguita C. [Conservative treatment of renal cell carcinoma in kidney transplantation]. Actas Urol Esp 2013; 37:242-8. [PMID: 23246102 DOI: 10.1016/j.acuro.2012.07.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2012] [Revised: 07/09/2012] [Accepted: 07/28/2012] [Indexed: 01/15/2023]
Abstract
PURPOSE To evaluate the new treatment strategies in renal cell carcinoma (RCC) that affects the graft in renal recipients. ACQUISITION OF EVIDENCE A literature review is made, analyzing all the published cases of conservative surgery in renal graft RCC. SYNTHESIS OF EVIDENCE A total of 51 partial nephrectomies in renal graft patients have been described, with a graft survival rate of 88% and a recurrence rate of 6%. Most of the patients (75%) were asymptomatic at the time of diagnosis, and the mean lesion size was 2.8 cm. Enucleation was the most frequent technique employed. 77% of all immunosuppressor regimens included cyclosporine A. Six patients with graft RCC were subjected to radiofrequency ablation and two patients underwent percutaneous cryoablation, with a single case of relapse and a graft survival rate of 100%. CONCLUSIONS Nephron-sparing surgery is a good management option in renal graft RCC, affording good oncological control and graft survival. Modification of immunosuppression with the withdrawal of cyclosporine A and the introduction of mTOR inhibitors is an adequate measure in such patients.
Collapse
Affiliation(s)
- R González-López
- Servicio de Urología, Instituto de Investigaciones Sanitarias-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, España.
| | | | | | | | | |
Collapse
|
25
|
González-López R, Bueno-Serrano G, Vázquez-Escuderos J, Mayor-De Castro J, González-Enguita C. Conservative treatment of renal cell carcinoma in kidney transplantation. ACTA ACUST UNITED AC 2013. [DOI: 10.1016/j.acuroe.2012.07.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
26
|
Palou J, Angulo J, Ramón de Fata F, García-Tello A, González-Enguita C, Boada A, Sanz M. [Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection]. Actas Urol Esp 2013; 37:147-55. [PMID: 22995326 DOI: 10.1016/j.acuro.2012.06.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2012] [Accepted: 06/30/2012] [Indexed: 10/27/2022]
Abstract
OBJECTIVES To compare two therapeutic regimes in terms of bacterial eradication of post-menopausal with uncomplicated acute cystitis who complete antibiotic treatment. MATERIALS AND METHOD A multicenter, randomized, prospective and controlled study between two short antibiotic regimes: fosfomycin trometamol (FMT) 3g, 2 doses separated by 72hours and ciprofloxacin 250mg every 12hours for 3 days. A total of 118 post-menopausal women were enrolled in the study. They underwent an initial urine culture to know the responsible microorganism and susceptibility to treatment. This was repeated 5-7 days and 4 weeks after the treatment to evaluate bacterial eradication. Clinical symptoms and treatment safety were also evaluated. RESULTS There were microbiological data at the onset of the treatment in 82 women (69.49%). Of these, 27 did not have positive culture at the first visit (30.51%), 76 (64.41%) fulfilled all the protocol requirements and adverse effects from the treatment were collected in 113 (95.76%) of the patients enrolled in the study. The germs isolated most frequently were Escherichia coli (E. coli) (76.83%), Klebsiella pneumoniae (K. pneumoniae) (7.32%), Proteus mirabilis (P. mirabilis) (4.89%) and Enterococo sp. (3.66%). In terms of efficacy, no differences were detected in the proportion of patients who achieved bacterial eradication between the two study arms: 62.16% of the patients who received FMT and 58.97% of those treated with ciprofloxacin (chi-square, p=0.78). The proportion of patients who achieved clinical cure was also similar (86.49% for FMT and 82.05% for ciprofloxacin; square, p=0.59). These results indicate similar efficacy of both antibiotics in the treatment of uncomplicated lower tract urinary infection in post-menopausal women. In regards to safety data, the proportion of global adverse effects associated to the treatments was 3.45% for FMT and 9.09% for ciprofloxacin. Treatment compliance was 100% for FMT and 83.64% for ciprofloxacin. CONCLUSIONS The FMT administered at a dose of 3g every 72hours (2 total doses) and ciprofloxacin at a dose of 250mg every 12hours during 3 days (6 total doses) have a comparable efficacy profile in lower tract urinary infection in post-menopausal women who adequately comply with the treatment, also having comparable safety. The FMT has a better antimicrobial susceptibility profile and better rate of treatment compliance.
Collapse
|
27
|
Arance I, Ramón de Fata F, Angulo J, González-Enguita C, Errando C, Cozar J, Esteban M. [Available evidence about efficacy of different restoring agents of glycosaminoglycans for intravesical use in interstitial cystitis]. Actas Urol Esp 2013; 37:92-9. [PMID: 23260184 DOI: 10.1016/j.acuro.2012.10.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2012] [Accepted: 10/29/2012] [Indexed: 10/27/2022]
Abstract
OBJECTIVES To compare the different endovesical therapeutic regimes in terms of clinical effectiveness based on glycosaminoglycan replenishment agents (RA-GAG) available on the market in Spain. MATERIAL AND METHODS A bibliographic analysis was made of the studies published in Medline from 1996 to 2012 on RA-GAG of application in the bladder, placing emphasis on the clinical results. A post-hoc comparison was made of the efficacy of this treatment in the studies conducted in patients with interstitial cystitis in different conditions by calculating the effect sizes to analyze improvement on the pain visual analogue scale (VAS) and clinical response rate. The number of patients needed to treat (NNT) for the different agents was calculated based on the odds ratio and associated economic implications. RESULTS The globally available evidence is scarce. There are 38 articles about RA-GAGs in different indications, 71 of them in interstitial cystitis and only 8 may assist in establishing a comparison between the results presented. The treatments used were placebo, 0.8% high molecular weight hyaluronic acid (Cystistat(®)), 2% chondroitin sulfate sodium (Uracyst(®)) and a combination of 1.6% low molecular weight hyaluronic acid plus 2% chondroitin sulfate (Ialuril(®)), between 6 and 12 instillations. Another low molecular weight hyaluronic acid preparation (Uromac(®)) lacks any scientific evidence. All the therapeutic elements studied show a mean score decrease on the pain VAS and increase in the rate of post-treatment response. The NNT for the treatments that are statistically more beneficial over placebo ranges from 1.6 and 4.1. The post-hoc comparison of the response rates has established that Cystistat(®) 12 instillations (OR 18.8; 95% CI 6.4-57.2; P=.001) or 10 instillations (OR 19.2; 95% CI 5.3-75.3; P=.001) are the treatment regimes that obtain maximum effectiveness. In both cases, the NNT was 1.6. CONCLUSIONS This study has multiple limitations inherent to the nature of the design. However, although the available literature is scarce, it shows that there are differences regarding the clinical effectiveness of the different agents and regimes used for endovesical treatment of interstitial cystitis. These differences also entail economic type implications.
Collapse
|
28
|
González-Enguita C, Fernández-Aceñero M, García-Cardoso J, López-Pérez L, Manzarbeitia F, Vela-Navarrete R. [Relation between prostate gland volume and some histological markers of malignancy]. Actas Urol Esp 2012; 36:86-90. [PMID: 22188751 DOI: 10.1016/j.acuro.2011.10.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2011] [Revised: 10/14/2011] [Accepted: 10/14/2011] [Indexed: 10/26/2022]
Abstract
OBJECTIVES The relationship between the total volume of the prostate gland or its weight after radical prostatectomy and the histological markers of malignancy in cases of prostate cancer is a controversial subject. We have analyzed 100 consecutive radical prostatectomy specimens in order to determine the relationship between volume or weight of the prostate gland and the biological aggressiveness of the tumor process by different histological markers. MATERIAL AND METHODS One hundred consecutive radical prostatectomy specimens in patients who had not received pre-operative hormone treatment were retrospectively reviewed. These surgical samples were processed according to a standardized protocol. In a subsequent evaluation, the following were studied with greater detail: Gleason grade, tumor volume, multimodality, neural or vascular invasion, put stage, and presence of PIN foci. The histological findings were compared with the prostate gland weight using Windows SPAS, 13.0 statistical package with a significance value of p<0.05. According to the prostate gland weight, three groups were established: <40 g (33%), 40 - 90 g (61%), and >90 g (6%). RESULTS A statistically significant association (p=0.001) was found between the prostate gland weight and tumor volume since 15 of the 33 glands with weight under 40 g accounted for more than 50% of the glands affected by tumor compared to none of the 6 patients with total weight over 90 g. A significant relationship was also found between the multimodality and weight. (P=0.03), so that 24 of the 33 glands under 40 g had bilateral multimodality compared to only 1 out of the 6 glands over 90 g. The neural invasion, number of PIN foci and the highest combined Gleason grade were frequent in low volume prostates, but the difference did not reach statistical significance. CONCLUSIONS Our study indicates that large volume prostate glands have tumors with lower malignancy (tumor volume, bilateralism). This finding justifies the adequacy of using total volume of the prostate gland for diagnostic decision (indication of prostatic biopsy and their repetition) and the prognostic determination.
Collapse
|